CYTK
Price
$37.86
Change
-$0.33 (-0.86%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
4.57B
64 days until earnings call
HRMY
Price
$38.04
Change
+$0.87 (+2.34%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
2.14B
69 days until earnings call
Interact to see
Advertisement

CYTK vs HRMY

Header iconCYTK vs HRMY Comparison
Open Charts CYTK vs HRMYBanner chart's image
Cytokinetics
Price$37.86
Change-$0.33 (-0.86%)
Volume$24.92K
Capitalization4.57B
Harmony Biosciences Holdings
Price$38.04
Change+$0.87 (+2.34%)
Volume$1.85K
Capitalization2.14B
CYTK vs HRMY Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. HRMY commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and HRMY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (CYTK: $38.19 vs. HRMY: $37.17)
Brand notoriety: CYTK and HRMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 87% vs. HRMY: 47%
Market capitalization -- CYTK: $4.57B vs. HRMY: $2.14B
CYTK [@Biotechnology] is valued at $4.57B. HRMY’s [@Biotechnology] market capitalization is $2.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileHRMY’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • HRMY’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than CYTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 6 TA indicator(s) are bullish while HRMY’s TA Score has 6 bullish TA indicator(s).

  • CYTK’s TA Score: 6 bullish, 3 bearish.
  • HRMY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both CYTK and HRMY are a good buy in the short-term.

Price Growth

CYTK (@Biotechnology) experienced а +0.92% price change this week, while HRMY (@Biotechnology) price change was +2.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.93%. For the same industry, the average monthly price growth was +13.93%, and the average quarterly price growth was +30.97%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

HRMY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+3.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.57B) has a higher market cap than HRMY($2.14B). HRMY YTD gains are higher at: 8.021 vs. CYTK (-18.814). HRMY has higher annual earnings (EBITDA): 265M vs. CYTK (-504.83M). CYTK has more cash in the bank: 858M vs. HRMY (565M). HRMY has less debt than CYTK: HRMY (172M) vs CYTK (858M). HRMY has higher revenues than CYTK: HRMY (773M) vs CYTK (85.7M).
CYTKHRMYCYTK / HRMY
Capitalization4.57B2.14B214%
EBITDA-504.83M265M-191%
Gain YTD-18.8148.021-235%
P/E RatioN/A11.99-
Revenue85.7M773M11%
Total Cash858M565M152%
Total Debt858M172M499%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKHRMY
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
78%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLRTX10.350.07
+0.68%
NYLI Winslow Large Cap Growth Class R2
PMPRX15.93N/A
N/A
Principal MidCap Value I R3
PEDGX13.48N/A
N/A
Principal Edge MidCap Institutional
PAPTX11.14N/A
N/A
PACE Alternative Strategies P2
FCIKX17.16-0.02
-0.12%
NYLI PineStone International Eq Inv Cl

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-0.67%
SNBIF - HRMY
52%
Loosely correlated
N/A
CYTK - HRMY
37%
Loosely correlated
+3.19%
ANAB - HRMY
37%
Loosely correlated
-0.70%
LGND - HRMY
32%
Poorly correlated
+0.61%
AXON - HRMY
31%
Poorly correlated
+0.72%
More